Clin2
NCT07761546Worth exploringEnrolling by invitation

Ai-test: microbiome nutrition for low testosterone

Hypogonadism, MaleSecondary Hypogonadism

Part of Hormones & metabolism, Kidney & urinary, Mental health clinical trials.

This study tests whether a special diet can improve symptoms of low testosterone in men. It is intended to help men with certain symptoms like a low sex drive or trouble having erections and whose blood tests show low to borderline testosterone levels.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
112 people
Ages
30 years to 65 years
Study type
Interventional

Who can take part

  • Be a man aged 30 to 65 years old
  • Have had at least one sexual symptom (like low sex drive or erectile dysfunction) for at least 3 months
  • Have had two morning blood tests within the last few months that showed low-normal testosterone levels
  • Be in generally stable health without major medical conditions that are not well-controlled
  • Be willing to avoid taking testosterone or other sex-hormone medications for the 12-week study period

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07328542Not yet recruiting· Phase 4
Blood pressure monitoring study in men with low testosterone

This study examines how testosterone therapy affects blood pressure in men with low testosterone. It uses a 24-hour blood pressure monitor to track changes over time.

Birmingham, Alabama
NCT07752511Not yet recruiting
Stigma, identity, and quality of life in male hypogonadism

This study looks at how men with low testosterone (hypogonadism) feel about stigma, their sense of self, and their quality of life. It aims to understand these experiences better so that care can be improved.

Bingoel
NCT05249634Recruiting· Phase 2
Testosterone treatment study for men with chronic kidney disease

This Phase 2 study tests whether testosterone therapy can help men with chronic kidney disease who have low testosterone and related symptoms. It looks to see if treatment is safe and beneficial, while carefully checking heart, blood, prostate, and clotting risks.

St Louis, Missouri
NCT07278362Not yet recruiting· Phase 4
Testosterone therapy for men with low-risk prostate cancer on active surveillance

This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are not receiving active treatment. You may be eligible if you have confirmed low testosterone and are being monitored without intervention.

Miami, Florida
NCT06689085Recruiting· Phase 3
Testosterone replacement study for adolescent boys with low testosterone

This trial tests a testosterone injection (XYOSTED) to see if it's safe and effective for replacing testosterone in teenage boys who have low levels due to a known medical condition. It lasts 52 weeks, with an optional 2-year follow-up.

Los Angeles, California
NCT07028255Not yet recruiting
Testosterone supplement study for low energy in men

This trial tests whether a daily testosterone supplement can help men aged 28-65 who feel low energy, mood changes, or other symptoms linked to aging. It requires taking the supplement for several weeks and providing blood samples.

Carlsbad, California

Hear when a new Hypogonadism, Male trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.